Comparative QSAR studies on the novel series of thiazolones and tetrazole derivatives as HCV NS5B polymerase allosteric inhibitors

Letters in Drug Design and Discovery

Volumn 6, Issue 4, 2009, Pages 286-297

  Singh, Shalini ^a  

^a BAREILLY COLLEGE   (India)

Author keywords

DRAGON; HCVNS5B inhibitor; PRECLAV; QSAR; Tetrazole; Thiazolones

Indexed keywords

ANTIVIRUS AGENT; TETRAZOLE DERIVATIVE; THIAZOLE DERIVATIVE;

ARTICLE; CLASSIFICATION ALGORITHM; COMPUTER MODEL; COMPUTER PROGRAM; CONTROLLED STUDY; IC 50; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; VIRTUAL REALITY;

EID: 66349118604     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018009788452483     Document Type: Article

References (30)

1. rd ed.; Lippinocott-Raven Publishers, Philadelphia, USA, 1996, p. 931.
2. Maya, M. A.; Pringle, C. R. Virus taxonomy - 1997. J. Gen. Virol., 1998, 79, 649-657.
3. Khaja, M. N.; Munpally, S. K.; Hussain, M. M.; Habeebullah, C. M. Hepatitis C virus: The Indian scenario. Curr. Sci., 2002, 83(3), 219-224
4. Kolykhalov, A. A.; Mihalik, K.; Feinstone, S. M.; Rice, C. M. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo. J. Virol., 2000, 74, 2046-2051. (Pubitemid 30434065)
5. (a) Wu, J. Z.; Zhi, H. Targeting NS5B RNA-dependent RNA polymerase for anti-HCV chemotherapy. Curr. Drug Targets Infect. Disord., 2003, 3(3), 207.
6. (b) Clercq, E. D. Strategies in the design of antiviral drugs. Nat. Rev. Drug Disc., 2002, 1, 13.
7. Yan, S.; Larson, G.; Wu, J. Z.; Appleby, T.; Ding, Y.; Hamatake, R.; Hong, Z.; Yao, N. Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure. Bioorg. Med. Chem. Lett., 2007, 17, 63-67.
8. th street Gainesvilla, Florida, 326001, USA; 2006.
9. Allinger, N. L. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms. J. Am. Chem. Soc., 1977, 99(25), 8127-8134.
10. Allinger, N. L.; Yuh, Y. H. Quantam Chemistry program Exchange, Bloomington, Indiana, Program # 395, Burkert, U. Allinger, N. L. Molecular Mechanics, ACS Monograph, 1982, 177.
11. The Mopac93 program is available from Stewart, J. J. P. Fujitsu Ltd, Tokyo, Japan, 1993.
12. Tarko, L.; Lupescu, I.; Groposila-Constantinescu, D. QSAR Studies on amino-succinamic acid derivatives sweeteners. ARKIVOC, 2006, (xii), 22-40.
13. Tarko, L.; Lupescu, I.; Groposila-Constantinescu, D. Sweetness power QSARs by PRECLAV software. ARKIVOC, 2005, (x), 254-271. (Pubitemid 41075716)
14. The PRECLAV v. 0705 program is available from the Center of Organic Chemistry (CCO)- Romanian Academy; Bucharest, Romania, 2007, E-mail: pfilip@cco.ro
15. The DRAGON Plus v. 5. 5 program is available from Todeschini, R. Talete srl., via V. Pisani, 13-20124, Milano, Italy, 2007.
16. Tarko, L. QSAR studies regarding the inhibition of the carbonic anhydrase by the sulfonamides containing a picolinoyl group. Rev. Chim. (Bucuresti), 2007, 58, 191.
17. Tarko, L.; Supuran, C.T. QSAR studies for the inhibition of the transmembrane isozymes XII and XIV of human carbonic anhydrase with a series of sulfonamide. Bioorg. Med. Chem., 2007, 15, 5666-5671.
18. Singh, S.; Khadikar, P. V.; Scozzafava, A.; Supuran, C. T. QSAR studies for the inhibition of the transmembrane carbonic anhydrase isozyme XIV with sulfonamides using PRECLAV software. J. Enzyme Inhib. Med. Chem., 2008, iFirst article, 1-13. [URL: http://dx.doi.org/10.1080/4756360802187489, published on http://www.informaworld. com on 01 October 2008].
19. NCSS(Statistical Software Delux package), 329 North 1000 East; Kaysville, UT, USA, 2004.
20. Andrei, T.; Stancu, S.; Statistica, 1st ed., Editura Economica: Bu-. charest, 1995, p. 341.
21. Gálvez, J.; Garcìa, R.; Salabert, M. T.; Soler, R. Charge indexes. new topological descriptors. J. Chem. Inf. Comput. Sci., 1994, 34(3)520-525.
22. Hemmer, M. C.; Steinhauer, V.; Gasteiger, J. Deriving the 3D structure of organic molecules from their infrared spectra. Vib. Spectrosc., 1999, 19, 151-164.
23. Consonni, V.; Todeschini, R.; Pavan, M. Structure/response correlations and similarity/diversity analysis by GETAWAY descriptors. J. Chem. Inf. Comput. Sci., 2002, 42, 682-692.
24. Schuur, J. H.; Selzer, P.; Gasteiger, J. The coding of the three-dimensional structure of molecules by molecular transforms and its application to structure-spectra correlations and studies of biological activity. J. Am. Chem. Soc., 1996, 36, 334-344.
25. Ghose, A. K.; Viswanadhan, V. N.; Wendolowski, J. J. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. J. Comb. Chem., 1999, 1, 55-68.
26. Fukui, K. Theory of orientation and stereoselection, Springe-Verlag: Berlin, 1975.
27. Tarko, L. A procedure for virtual fragmentation of molecules into functional groups. ARKIVOC, 2004, (xiv), 74-82.
28. Tarko, L. Aromatic molecular zones and fragments. ARIKIVOC, 2008, (xi), 24-45.
29. Ivanciuc, O.; Ivanciuc, T.; Balban, T.A. QSAR Models for the Dermal Penetration of Polycyclic Aromatic Hydrocarbons. Interne. Electron. J. Mol. Des., 2002, 1, 566.
30. rd ed.; Wiley: New York, 2000.